CMS Expands Access to Lifesaving Gene Therapies Through Innovative State Agreements
CMS announced that 33 states, plus the District of Columbia and Puerto Rico, will participate in the Cell and Gene Therapy Access Model, a bold new approach to delivering cutting-edge treatments for people on Medicaid living with sickle cell disease.
